Loading company…
Tokyo-based consultancy for Software as a Medical Device (SaMD) and Digital Therapeutics (DTx) developers, founded in 2018.
Save Medical Corporation was founded in 2018 by Shotaro Asano, who serves as founder and CEO. It consults on business strategy, regulatory affairs and Quality Management System development for companies building Software as Medical Devices, and supports Digital Therapeutics commercialization from concept to market launch. Clients are mostly healthcare providers and technology firms, and fees are mainly fixed with possible performance-based incentives. The company completed 4 deals, most recently a Series C round of JPY 50 million on July 22, 2024 from TIS.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in